Dyne Therapeutics DYN
$15.50 −$0.53 (-3.31%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $15.50 0.00%
Open$15.91
Prev close$16.03
Day range$15.41 – $16.48
Volume2.23M
Market cap$2.90B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts10
Average target$34.90+125.2% vs. price
- Buy 90%
- Sell 10%
Low $10.00Now $15.50Avg $34.90High $50.00
Recent rating changes
The last 20 actions on file set price targets from $10.00 to $50.00, averaging $36.50.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 11 Nov 2026 | Raymond James | BUY | $41.00 |
| 6 Nov 2026 | Morgan Stanley | BUY | $36.00 |
| 6 Nov 2026 | H.C. Wainwright | BUY | $32.00 |
| 5 Nov 2026 | RBC Capital | BUY | $30.00 |
| 30 Sep 2026 | LifeSci Capital | BUY | $40.00 |
| 30 Sep 2026 | Stifel | BUY | $37.00 |
| 30 Sep 2026 | H.C. Wainwright | BUY | $32.00 |
| 29 Sep 2026 | Piper Sandler | BUY | $47.00 |
| 23 Sep 2026 | Raymond James | BUY | $37.00 |
| 9 Sep 2026 | Baird | BUY | $26.00 |
| 9 Sep 2026 | Morgan Stanley | BUY | $36.00 |
| 8 Sep 2026 | LifeSci Capital | BUY | $40.00 |
| 8 Sep 2026 | Jefferies | BUY | $50.00 |
| 8 Sep 2026 | Stifel | BUY | $37.00 |
| 8 Sep 2026 | RBC Capital | BUY | $30.00 |
| 8 Sep 2026 | J.P. Morgan | SELL | $10.00 |
| 25 Aug 2026 | Raymond James | BUY | $40.00 |
| 4 Aug 2026 | Raymond James | BUY | $40.00 |
| 31 Jul 2026 | LifeSci Capital | BUY | $44.00 |
| 31 Jul 2026 | Morgan Stanley | BUY | $45.00 |
No comments yet — be the first to weigh in on DYN.
Sign in to join the discussion.